Genomic profiling of relapsed small cell lung cancer reveals potential pathways of therapeutic targets

CONCLUSIONS: Our studies first exhibited comprehensive genomic profiling of relapsed SCLC, identifying several candidate genes, and briefly analyzed the association of survival and genomic alterations. Our data from a small cohort of relapsed SCLC will benefit further exploration the potential targets or biomarkers.PMID:38249912 | PMC:PMC10797366 | DOI:10.21037/jtd-23-1657

Source: Journal of Thoracic Disease - January 22, 2024 Category: Respiratory Medicine Authors: Wen Ouyang Jing Yu Zihang Zeng Jun Gong Junhong Zhang Conghua Xie Source Type: research